Toll Free: 1-888-928-9744

Congenital Heart Disease Global Clinical Trials Review, H1, 2016

Published: Apr 15, 2016 | Pages: 184 | Publisher: GlobalData | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Congenital Heart Disease Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, "Congenital Heart Disease Global Clinical Trials Review, H1, 2016" provides an overview of Congenital Heart Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Congenital Heart Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
 Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13 Top Countries Contributing to Clinical Trials in Central and South America 14 Clinical Trials by G7 Countries: Proportion of Congenital Heart Disease to Cardiovascular Clinical Trials 15 Clinical Trials by Phase in G7 Countries 16 Clinical Trials in G7 Countries by Trial Status 17 Clinical Trials by E7 Countries: Proportion of Congenital Heart Disease to Cardiovascular Clinical Trials 18 Clinical Trials by Phase in E7 Countries 19 Clinical Trials in E7 Countries by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Clinical Trials by End Point Status 24 Subjects Recruited Over a Period of Time 25 Clinical Trials by Sponsor Type 26 Prominent Sponsors 27 Top Companies Participating in Congenital Heart Disease Therapeutics Clinical Trials 28 Prominent Drugs 30 Latest Clinical Trials News on Congenital Heart Disease 31 Mar 23, 2016: Mezzion Pharma Receives Special Protocol Assessment Agreement From FDA For Udenafil Phase 3 Studies In Adolescents With Single Ventricle Congenital Heart Disease With Fontan Physiology 31 Clinical Trial Profile Snapshots 32 Appendix 181 Abbreviations 181 Definitions 181 Research Methodology 182 Secondary Research 182 About GlobalData 183 Contact Us 183 Disclaimer 183 Source 184
List of Tables
Congenital Heart Disease Therapeutics, Global, Clinical Trials by Region, 2016* 6 Congenital Heart Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8 Congenital Heart Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Congenital Heart Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10 Congenital Heart Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11 Congenital Heart Disease Therapeutics Clinical Trials, North America, Top Countries, 2016* 12 Congenital Heart Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 13 Congenital Heart Disease Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 14 Proportion of Congenital Heart Disease to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 15 Congenital Heart Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Congenital Heart Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Congenital Heart Disease to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 18 Congenital Heart Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Congenital Heart Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Congenital Heart Disease Therapeutics, Global, Clinical Trials by Phase, 2016* 21 Congenital Heart Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 22 Congenital Heart Disease Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Congenital Heart Disease Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Congenital Heart Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Congenital Heart Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 26 Congenital Heart Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Congenital Heart Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29 Congenital Heart Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30


List of Figures
Congenital Heart Disease Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Congenital Heart Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Congenital Heart Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Congenital Heart Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10 Congenital Heart Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11 Congenital Heart Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12 Congenital Heart Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 13 Congenital Heart Disease Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 14 Proportion of Congenital Heart Disease to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 15 Congenital Heart Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Congenital Heart Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Congenital Heart Disease to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 18 Congenital Heart Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Congenital Heart Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Congenital Heart Disease Therapeutics, Global, Clinical Trials by Phase (%), 2016* 21 Congenital Heart Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 22 Congenital Heart Disease Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Congenital Heart Disease Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Congenital Heart Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Congenital Heart Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 26 Congenital Heart Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Congenital Heart Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28 Congenital Heart Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30 GlobalData Methodology 182

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global automotive electronics market size forecast is likely to reach USD 279.96 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing application scope of these equipments is estimated to drive industry growth. Increasing i

Read More...

Global FPGA market is anticipated to be valued at USD 9,882.5 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing demand for customized IC’s is expected to drive the demand. Customized IC’s helps manufacturers to mo

Read More...

Global polymethyl methacrylate (PMMA) market size is likely to be valued at USD 11.65 billion by 2022; as per a new research report by Radiant Insights, Inc. Increasing spending on advertising & marketing for building strong brand equity and product

Read More...

Global thermoplastic polyurethane (TPU) films market size is likely to be valued at USD 724.6 million by 2020; as per a new research report by Radiant Insights, Inc. Increase in lightweight plastics demand in order to achieve vehicle fuel efficiency

Read More...

Global lignin market size is expected to exceed USD 6 billion by 2022, growing at 4.9% from 2015 to 2022. Rising demand for animal feed and potential as a feedstock substitute to crude oil are expected to drive lignin market demand over the forecast

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify